Incidence of solid cancer in patients with follicular lymphoma

Acta Oncologica
Marc SorigueOuti Kuittinen

Abstract

Introduction: Patients with follicular lymphoma (FL) have classically had a higher risk of solid cancers than the general population, but there is little data available in patients diagnosed and treated with modern day regimens.Material and methods: We conducted a retrospective multicenter study assessing the cumulative incidence of solid cancers other than nonmelanoma skin cancer in patients with FL between 1997 and 2016 and determined the standardized incidence ratio (SIR) to compare the incidence of solid cancers with that of the general populationResults: Among 1002 FL patients with 7 years of median follow-up, we found 74 solid cancers (most common breast [n = 19], lung and colon [n = 9 each]). The cumulative incidence was 3.8% at 5 years (95%CI 2.6-5.2) from the time of diagnosis and 4.4% at 5 years (95%CI 3.1-5.9%) from the time of front-line treatment. Although a comparison of all front-line strategies did not reveal differences in the risk of solid cancers, patients treated with anthracycline-based regimens appeared to have a lower incidence than those treated with bendamustine-based strategies (2.8% vs. 6.9%). However, patients receiving the former regimen were younger than the latter. On multivariable analysis, older...Continue Reading

References

Jun 23, 2005·British Journal of Cancer·P BrennanP Boffetta
Mar 8, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nadejda Y MudieDavid C Linch
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James C Yang, Richard Childs
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Jan 27, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Haesook T Kim
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan W FriedbergBrian K Link
Oct 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lindsay M MortonJoseph F Fraumeni
Feb 12, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M PiraniS Sacchi
Mar 30, 2013·Science·Bert VogelsteinKenneth W Kinzler
May 7, 2013·Haematologica·Emmanuel BachyUNKNOWN Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Sep 7, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I El-NajjarUNKNOWN Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Oct 21, 2016·American Journal of Hematology·Matthew J MaurerBrian K Link
Sep 13, 2016·CA: a Cancer Journal for Clinicians·Lauren R TerasChristopher R Flowers
Jul 16, 2017·Clinical Lymphoma, Myeloma & Leukemia·Smith GiriJames O Armitage
Oct 5, 2017·The New England Journal of Medicine·Robert MarcusWolfgang Hiddemann
Feb 10, 2018·Nature Reviews. Cancer·Sarah HuetGilles Salles
Feb 18, 2018·Best Practice & Research. Clinical Haematology·Tracy LackrajRobert Kridel
May 13, 2018·Annals of Hematology·Marc Sorigue, Juan-Manuel Sancho
Jun 2, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfgang HiddemannRobert E Marcus
Oct 5, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sandra LockmerEva Kimby
Feb 28, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian W FlinnJohn M Burke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Chunkit FungLois B Travis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
S BhatiaLate Effects Study Group
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
S BhatiaS J Forman
Pharmacoepidemiology and Drug Safety
Kevin HaynesJames D Lewis
[Rinshō ketsueki] The Japanese journal of clinical hematology
Koji Izutsu
© 2021 Meta ULC. All rights reserved